Targeting Ocular Disorders


With the aging of the population, the need for treatments of ocular diseases and disorders has become more critical than ever. Increasingly high incidences of age-related macular degeneration (AMD), glaucoma, diabetic retinopathy and ocular inflammatory diseases demand better, more effective and innovative treatments. If we are to maintain the quality of life for these people, the preservation of vision is critical. This conference will address drug targeting, novel and emerging treatments, along with novel and emerging pathways that hold promise in treating these crippling conditions.

Visitors

Researchers in drug discovery and development for ophthalmic/
ocular drugs and biologics
VP of R & D for ocular drugs/biologics
Group Leader, Ophthalmic Drug Discovery
Researchers in Glaucoma, Macular Degeneration, Dry Eye, optic allergy, uveitis

Exhibitors

CHI offers comprehensive sponsorship packages which include presentation opportunities, exhibit space and branding, as well as the use of the pre and post-show delegate list. Sponsorship allows you to achieve your objectives before, during, and long after the event. Any sponsorship can be customized to meet your company’s needs and budget. Signing on earlier will allow you to maximize exposure to hard-to-reach decision-makers.

Go to event website